
Business Weekly
Business Daily
00:00
Is the FDA Approval of Aduhelm a Good Idea?
The controversy surrounding its approval isn't just about science or process. There is also a big issue of cost that all the people i spoke with highlighted. And i do think that this aducanamab could becoe of a watershed moment of the need to revisit why do we have accelerated approval? How should it be used? Are the regulations really working to help improve the health and well of people with serious and life threatening diseases? Or are they more serving kind of business interests that are seeking to get things out as quick as possible and maximase the return on investment?
Transcript
Play full episode